Postnatal therapy for organ growth and repair

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1003806

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The study of growth factors essential in normal kidney and lung development allows for the advancement of innovative therapies to promote postnatal growth and repair. A revolutionary new therapy for treatment of growth restricted fetuses and premature babies is being developed through the administration of colony stimulating factor (CSF-1), a growth factor important for fetal growth during pregnancy. We have evidence that CSF-1 therapy can promote lungs to continue development and maturation after birth.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $541,652.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

colony stimulating factors (CSF) | kidney development | lung development | lung disease | macrophages | premature infant | urogenital disorders

Related Links